2749 E. PARLEYS WAY, SALT LAKE CITY, UT
Market cap: $100.8M (2/08/2026)
Price: $2.68
Investor Presentation
Landmark Study Finds Blood Test Reduces Earliest Preterm Births and Newborn Complications
Announces Publication Acceptance for PRIME Study
Earnings Release
Reg. FD
Shareholder votes
Appoints Lee Anderson as Chief Commercial Officer
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
SEC Staff Correspondence
Correspondence